Serina Therapeutics (SER) Other financing activities (2018 - 2025)

Serina Therapeutics has disclosed Other financing activities across 7 years of filings, most recently posting $5000.0 for Q4 2025.

• In Q4 2025, Other financing activities changed N/A year-over-year to $5000.0; the TTM figure through Dec 2025 stood at $15000.0 (down 99.7% YoY), while the FY2025 annual figure was $15000.0, down 99.7% from the prior year.
• Other financing activities came in at $5000.0 for Q4 2025 at Serina Therapeutics, down from $8000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $5.0 million in Q2 2024 to a low of -$2.2 million in Q2 2021.
• Average Other financing activities over 4 years is $529666.7, with a median of $5000.0 recorded in 2025.
• The largest YoY upside for Other financing activities was 900.0% in 2021 against a maximum downside of 190.0% in 2021.
• Over 4 years, Other financing activities stood at -$2.2 million in 2021, then jumped by 100.62% to $14000.0 in 2023, then soared by 35500.0% to $5.0 million in 2024, then plunged by 99.9% to $5000.0 in 2025.
• Per Business Quant data, the three most recent Other financing activities figures were $5000.0 in Q4 2025, $8000.0 in Q3 2025, and $1000.0 in Q2 2025.